Pfizer and AZ Covid jabs 'highly effective' in elderly, finds UK study

The study showed that for those above 80, a single dose of either vaccine is more than 80 per cent effective at preventing hospitalisation around three to four weeks after the jab.

published on : 2nd March 2021

US loosens Pfizer vaccine shipping regulations

The FDA said the vaccine, which is shipped in frozen vials, now can be transported and stored for up to two weeks at the temperatures of freezers commonly found in pharmacies.

published on : 26th February 2021

Pfizer, BioNTech begin testing of third dose against new COVID-19 variants

The study will evaluate up to 144 Phase 1 participants in two age cohorts, 18-55 and 65-85 years of age.

published on : 25th February 2021

Mass 'real world' study confirms Pfizer COVID vaccine 94 percent effective

The good news came as Ghana became the first country to receive shots under the global Covax scheme, paving the way for poorer nations to catch up with wealthier parts of the world.

published on : 25th February 2021

Vaccines substantially reduce COVID-19 hospitalisations: Scotland study

About 650,000 people in Scotland received the Pfizer vaccine during the study period and 490,000 had the AstraZeneca shot, according to the Usher Institute. 

published on : 22nd February 2021

Pfizer-BioNTech to get EU 200 million more COVID-19 shots

The US and German companies said in a statement that the doses come on top of the 300 million initially ordered.

published on : 17th February 2021

North Korea 'tried to hack' Pfizer's systems for COVID vaccine information: Intelligence report

North Korean leader Kim Jong Un has repeatedly insisted that the country has had no coronavirus cases, although outside experts doubt those assertions.

published on : 16th February 2021

Australia receives over 142,000 Pfizer vaccine doses; vaccination drive from February 22

Prime Minister Scott Morrison will also be among the first to receive a dose in a bid to raise public confidence in the program.

published on : 15th February 2021

For the first time, Oxford Covid-19 vaccine to be tested on children

The trial announced Saturday seeks to recruit 300 volunteers between the ages of 6 and 17, with up to 240 receiving the COVID-19 vaccine and the remainder a control meningitis vaccine.

published on : 13th February 2021

Pfizer suggests COVID vaccine as 'perfect gift' for valentine's day in parody ad on Jimmy Kimmel show

The advertisement that is now viral shows a man ‘proposing' to his partner with a dose of the COVID-19 vaccine.

published on : 12th February 2021

COVID-19 vaccine: Pfizer withdraws Emergency Use Authorisation application in India

Pfizer will continue to engage with the authority and resubmit its approval request with additional information as it becomes available in the near future, the statement said.

published on : 5th February 2021

Australia allows Pfizer COVID vaccine for all ages

Australia's Therapeutic Goods Administration said in a statement Tuesday that it received reports on January 14 of about 30 deaths in more than 40,000 elderly people vaccinated with Pfizer.

published on : 3rd February 2021

Pfizer estimates USD 15 billion in 2021 sales for Covid-19 vaccine

Pfizer's fourth-quarter revenues included $154 million in sales of the Covid-19 vaccine.

published on : 2nd February 2021

Pfizer swings to a profit, but misses Street expectations

The drugmaker expects roughly $15 billion in revenue this year from the vaccine, which won emergency clearance in mid-December in the US regulators and continues to rack up approvals across the globe.

published on : 2nd February 2021

Europe regulator: No new vaccine side effects

The EMA concluded that safety data collected on the Pfizer vaccine are “consistent with the known safety profile of the vaccine” and noted that severe allergic reactions are a known, rare side effect.

published on : 29th January 2021
1 2 3 4 5 6 >